Korea
VUNO Med(R)-Fundus AI(TM) receives MFDS Regulatory Approval as Class III Medical Device
SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- VUNO, a member company of the Born2Global Centre, announced that their AI based screening solution for the fundus, VUNO Med®-Fundus AI™ is approved as a Class III medical device by the Ministry of Food and Drug Safety. VUNO Med®-Fundus AI™ is the f...
Smart speaker broadcasts made easy through Wecast.ai
SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- South Korean startup, NextN est, has launched Wecast.ai, a broadcasting platform for the widely used voice assistant technologies, Amazon Alexa and Google Assistant. Wecast makes voice broadcast creation a simple task for anyone. Following an intu...
AITRICS and Cleveland Clinic collaborate to verify AI-based sepsis prediction solution
SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- AITRICS, a Korea-based startup offering AI solutions, has signed a joint research agreement with Cleveland Clinic, a general hospital located inCleveland, Ohio. Two parties will collaborate on verifying VitalCare, AITRICS's AI platform, that pred...
VisualCamp launches 'SeeSo' website, mobile eye tracking SDK
SAN JOSE, Calif., April 13, 2020 /PRNewswire/ -- VisualCamp, a member company of theBorn2Global Centre, has launched its "SeeSo" websiteon April 13, a mobile eye tracking and gaze analytic SDK that allows developers to know where users are looking and their concentration. SeeSo website is an SDK...
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment
SONGDO, South Korea and SAN FRANCISCO, April 9, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced a manufacturing agreement under which Samsung Biologics will perform large scale manufacturing services for Vir's SARS-CoV-2 monoclonal anti...
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis
* The Interim data showed that 3 out of 9 evaluable patients on BBT-401 responded with more than 30% reduction in Total Mayo Score or 25% reduction in Partial Mayo Score * Safety and tolerability profiles remain consistent with results from Phase I trial in healthy volunteers SEONGNAM, South ...
Samsung Biologics named Champion in 2020 CMO Leadership Awards
SONGDO, South Korea, April 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced that it has been awarded the 2020 CMO Leadership Awards for its excellence in the Capabilities, Compatibility, Quality, Reliability, and Service categories across Big Pharma and Overall (combined Big and Sm...
GenScript ProBio and Eutilex Enter into Exclusive Strategic Collaboration on Plasmid and Virus Process Development and Manufacturing for CAR-T Programs
NANJING, China and SEOUL, South Korea, April 7, 2020 /PRNewswire/ -- GenScript Biotech Corporation's CDMO business GenScript ProBio (hereinafter referred to as GenScript ProBio) and Eutilex Co., Ltd. (hereinafter referred to as Eutilex) committed to developing anti-cancer immunotherapy technology...
THE.WAVE.TALK raises US$2M
SEOUL, South Korea, April 7, 2020 /PRNewswire/ -- THE.WAVE.TALK, a member company of theBorn2Global Centre, successfully attracted a funding of USD 2 million in early February from Yellowdog and Silicon Valley-based Big Basin Capital, bringing its accumulated total to approximately USD 6 million ...
SK hynix's Low-Power NVMe PCIe Gen4 Enterprise SSDs: Available Now for Sampling
SEOUL, South Korea, April 7, 2020 /PRNewswire/ -- SK hynix Inc. (or "the
Company,"www.skhynix.com
Bespin Global receives Google Cloud '2019 Reseller Partner of the Year for Asia Pacific' Award
* Bespin Global is awarded the Google Cloud Partner Award for 2 consecutive years, after winning '2018 Breakthrough Partner of the Year forAsia Pacific' award in 2019. * The award recognizes Bespin Global's success in generating Google Cloud related business opportunities inSouth Korea and ...
Yuyu Pharma appoints Robert Wonsang Yu as incoming President and CEO
SEOUL, South Korea, April 5, 2020 /PRNewswire/ -- Yuyu Pharma (KRX: 000220), a
global pharmaceutical company based in Korea, is pleased to announce the
appointment of Mr.Robert Wonsang Yu as President and Chief Executive Officer
effectiveApril 6, 2020.
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
SONGDO, South Korea, April 5, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline, a next generation therapeutic antibody candidate to treat oncology and neovascular disorders. Under th...
VUNO offers a suite of AI solutions in response to the COVID-19 outbreak: VUNO Med(R)- LungQuant(TM) and VUNO Med(R)-Chest X-ray(TM): COVID-19
SEOUL, South Korea, April 3, 2020 /PRNewswire/ -- In the face of the COVID-19 pandemic raging around the globe,VUNO, a member company of the Born2Global Centre, has decided to move quickly by joining the global coalition to help address some critical issues facing the international healthcare com...
WONTECH Receives FDA Clearance for 'SANDRO DUAL'
SEOUL, South Korea, April 1, 2020 /PRNewswire/ -- WONTECH (Reno Kim, CEO of
WONTECH,www.wtlaser.com
Vietmate, Following Vietnam, Signs Official Contract with Ralali, the No.1 B2B Electronic Commerce Platform in Indonesia
PANGYO, South Korea, March 31, 2020 /PRNewswire/ -- Vietmate Inc., a company entering the ICT-Culture Integration Center operated by the Ministry of Science and ICT and the National IT Industry Promotion Agency, revealed that they had signed an official 30 day contract with 'Ralali', the No.1 B2B...
Yuyu Pharma introduces enhanced ERP system
SEOUL, South Korea, March 31, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert
Wonsang Yu, KRX 000220) introduced a new Enterprise Resource Planning (ERP)
system to identify real-time management conditions and enhance system
management for more efficient decision-making.
ImmuneMed's 'hzVSF,' Used for Treatment of COVID-19 Pneumonia Patients
CHUNCHEON, South Korea, March 30, 2020 /PRNewswire/ -- 'hzVSF v13 (humanized Virus Suppressing Factor; VSF)', a treatment that can be used for a wide range of viral diseases developed by ImmuneMed, was administered onMarch 28th at Yonsei University Hospital to treat COVID-19 pneumonia patients...
Samsung Biologics expands leadership for CDO business
SONGDO, South Korea, March 30, 2020 /PRNewswire/ -- Samsung Biologics
(207940.KS) has appointedEun Young Yang as vice president of business
development for the company's expanded CDO (contract development organization)
business.
Hyundai Capital Services' Next Generation System to facilitate global expansion
* Hyundai Capital America is the first among 11 global entities to introduce NGS * NGS is set to boost marketing capabilities and reduce time and cost * Launch of NGS in Canada and China entities is being considered SEOUL, South Korea, March 26, 2020 /PRNewswire/ -- Hyundai Capital Services ...
Week's Top Stories
Most Reposted
Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 305 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 299 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 283 media titles]
2024-11-20 09:00